Cleared Traditional

K914204 - TRI-POINT LIQUIMMUNE LIGAND CONTROL LEVELS 1,2,3

K914204 is an FDA 510(k) clearance for TRI-POINT LIQUIMMUNE LIGAND CONTROL LEV..., manufactured by Medical Analysis Systems, Inc.. The device is a Class 1 Chemistry device with product code JJY cleared through the Traditional 510(k) pathway after a 180-day FDA review.

K914204 · Medical Analysis Systems, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1992
Decision
180d
Days
Class 1
Risk

K914204 is an FDA 510(k) clearance for the TRI-POINT LIQUIMMUNE LIGAND CONTROL LEVELS 1,2,3. Classified as Multi-analyte Controls, All Kinds (assayed) (product code JJY), Class I - General Controls.

Submitted by Medical Analysis Systems, Inc. (Camarillo, US). The FDA issued a Cleared decision on March 17, 1992 after a review of 180 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Medical Analysis Systems, Inc. devices

FDA 510(k) Submission Details - K914204

510(k) Number K914204 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 19, 1991
Decision Date March 17, 1992
Days to Decision 180 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
92d slower than avg
Panel avg: 88d · This submission: 180d
Pathway characteristics
Predicate-based equivalence.

JJY Device Classification - Class 1, General Controls

Product Code JJY Multi-analyte Controls, All Kinds (assayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJY Multi-analyte Controls, All Kinds (assayed)

All 594
Devices cleared under the same product code (JJY) and FDA review panel - the closest regulatory comparables to K914204.
AMERLITE FREE THYROID CONTROL SERA LAN.4002
K920940 · Eastman Kodak Company · Apr 1992
HUMAN CHORIONIC GONADATROPHIN AND UNCON. ESTRIOL
K920826 · Eastman Kodak Company · Apr 1992
CHEM-CHEM MULTI-ANALYTE (MODIFIED)
K920350 · Streck Laboratories, Inc. · Mar 1992
N/T PROTEIN CONTROL UY
K914890 · Behring Diagnostics, Inc. · Feb 1992
LIQUICHEK(R) UNASSAYED CHEMISTRY CONTR(HUMAN) 1&2
K914255 · Bio-Rad · Jan 1992
RAI-TROL ELEVATED LIPIDS CONTROL
K915191 · Reagents Applications, Inc. · Dec 1991